YOLFTbeta
Integrum AB Series B

Integrum AB Series B

INTEG-B · ST · Healthcare / Medical Devices

8.19SEK-0.07 (-0.85%)

Price History

Full chart

Market Stats

Previous Close8.26
Open8.09
Day Range8.07 – 8.44
52-Week Range6.40 – 12.98
Volume24.90K
Market Cap238.94M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.42
Dividend Yield0.00%
Beta0.39
50-Day Avg8.82
200-Day Avg8.52

About

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. It also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was incorporated in 1990 and is headquartered in Mölndal, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Martin Hillsten
  • Employees33
  • HeadquartersGemenskapens gata 9, Mölndal, Sweden, 431 53, Sweden
  • Websitehttps://integrum.se

Leadership

  • Dr. Rickard BranemarkFounder, Owner, Chief Medical & Scientific Officer and Chairman of the Board · b. 1960
  • Mr. Martin HillstenChief Executive Officer · b. 1978
  • Ms. Louise WahlinChief Financial Officer
  • Annika FahlénChief Compliance & Development Officer
  • Mr. Per M. NilssonChief Supply & IT Officer
  • Ms. Anna-Tove BranemarkChief Executive Officer of Integrum Inc. · b. 1967

Financials

Income Statement

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue19.00M14.83M12.27M17.81M15.17M22.45M26.75M43.09M55.72M74.27M104.12M91.10M91.39M
Growth (%)--21.94%-17.30%+45.22%-14.81%+47.95%+19.14%+61.12%+29.31%+33.29%+40.19%-12.50%+0.31%
Cost of Revenue3.62M3.45M735.00K-737.00K3.70M4.90M5.38M8.21M9.17M13.43M12.86M15.72M28.16M
Gross Profit15.38M11.38M11.53M18.55M11.48M17.55M21.37M34.89M46.56M60.84M91.26M75.38M63.23M
Gross Margin80.93%76.73%94.01%104.14%75.63%78.18%79.88%80.96%83.55%81.92%87.65%82.75%69.19%
Operating Expense12.36M12.18M11.34M24.68M30.25M42.13M37.05M36.74M45.52M80.55M84.75M117.76M114.75M
Operating Income3.02M-796.00K192.00K-6.13M-18.77M-24.58M-15.68M-1.85M1.04M-19.70M6.51M-42.38M-51.52M
Operating Margin15.88%-5.37%1.57%-34.42%-123.73%-109.49%-58.63%-4.30%1.86%-26.53%6.25%-46.51%-56.38%
EBITDA3.29M286.00K319.64K-5.82M-18.13M-23.96M-14.98M-1.59M2.60M-20.24M8.76M-35.50M-39.62M
EBITDA Margin17.32%1.93%2.61%-32.67%-119.50%-106.75%-56.02%-3.68%4.67%-27.25%8.41%-38.96%-43.36%
Net Income1.72M176204-5.75M-18.36M-24.58M-15.69M-2.14M21.27M-16.18M4.03M-30.85M-46.34M
Net Income Margin9.05%0.00%0.00%-32.26%-120.99%-109.50%-58.65%-4.97%38.17%-21.79%3.87%-33.87%-50.71%
R&D---78.90K86.08K86.08K86.08K86.08K-2.44M249.82K--
R&D as % of Total Revenue---0.44%0.57%0.38%0.32%0.20%-3.29%0.24%--
Interest Expense86.71K69.00K187.71K1.16M259.55K189.19K215.01K84.76K16.90K10.02K559.63K479.00K614.00K
Interest Expense % of Total Revenue0.46%0.47%1.53%6.51%1.71%0.84%0.80%0.20%0.03%0.01%0.54%0.53%0.67%

Balance Sheet

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets8.64M6.42M10.17M19.77M26.38M24.90M32.20M37.21M180.44M165.17M164.86M203.25M203.60M
Total Liabilities5.62M5.28M9.03M9.24M8.38M8.85M8.47M12.91M20.70M21.64M22.07M25.38M31.59M
Total Equity3.02M1.13M1.14M10.53M18.00M16.05M23.73M24.29M159.74M143.53M142.79M177.88M172.01M
Cash2.41M508.00K590.00K6.81M13.90M10.62M13.06M7.66M75.34M41.92M16.90M39.60M19.06M
Total Debt1.29M1.09M3.89M3.31M2.36M1.41M723.81K1.54M580.89K7.92M6.42M4.84M3.17M
Net Debt-1.12M582.00K3.30M-3.49M-11.54M-9.21M-12.34M-6.12M-74.76M-34.01M-10.48M-34.76M-15.89M

Cash Flow

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--663.00K-2.74M-3.01M-17.45M-25.28M-18.72M-5.76M-20.28M-25.10M-12.74M-37.70M-41.02M
Investing Cash Flow---652.00K-5.70M-506.42K-192.48K-343.68K-1.71M-29.27M-11.40M-11.63M-12.89M-16.94M
Financing Cash Flow--1.20M3.49M14.66M25.05M22.19M21.51M2.06M117.23M3.08M-648.54K73.29M37.43M
Capital Expenditure00652.00K5.70M506.42K192.48K343.68K1.71M29.27M11.40M11.63M12.89M41.02M
Free Cash Flow--663.00K-3.39M-8.72M-17.96M-25.47M-19.06M-7.47M-49.55M-36.50M-24.37M-50.59M-57.96M
Dividends Paid-1.00M-----------
FCF to OCF-100.00%123.80%289.26%102.90%100.76%101.84%129.63%244.32%145.43%191.24%134.18%141.29%
Dividend Paid to FCF--150.83%-----------

Earnings

Report DateMar 6, 2017Aug 28, 2017Dec 18, 2017Mar 26, 2018Jun 25, 2018Sep 21, 2018Dec 5, 2018Mar 4, 2019Jun 10, 2019Sep 2, 2019Dec 2, 2019Mar 2, 2020Jun 8, 2020Aug 23, 2020Dec 2, 2020Mar 31, 2021May 31, 2021Sep 2, 2021Dec 2, 2021Mar 2, 2022Jun 10, 2022Aug 31, 2022Dec 1, 2022Mar 1, 2023Jun 8, 2023Aug 31, 2023Dec 4, 2023Feb 29, 2024May 29, 2024Aug 27, 2024Dec 3, 2024Mar 2, 2025Jun 3, 2025Sep 1, 2025Nov 21, 2025Mar 5, 2026Jun 4, 2026Sep 3, 2026Dec 3, 2026
EPS Estimate0.00-------------------0.00-----0.210.050.060.05-0.39-0.39-0.30-0.16-0.02-0.39-0.30-0.16-0.02
EPS Actual-0.16-0.75-0.27-0.89-0.79-0.63-0.15-0.68-0.68-0.35-0.18-0.26-0.30-0.210.200.02-0.040.070.900.030.18-0.030.13-0.740.35-0.160.210.040.12-0.49-0.46-0.18-0.42-0.47-0.35-0.35-0.660.03-
Surprise--------------------------0.29%-10.40%100.00%-1080.00%-17.95%53.85%-40.00%-193.75%-1650.00%10.26%-118.37%120.44%-
Timing----------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap238.94M
Enterprise Value239.06M
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.44
Price / Book1.46
EPS-1.42
Book Value6.53
Revenue (TTM)97.90M
Gross Profit (TTM)70.47M
EBITDA-26.08M
Profit Margin-36.27%
Operating Margin7.43%
Return on Equity-20.75%
Return on Assets-11.81%
Shares Outstanding26.03M
Shares Float16.15M
Beta0.39
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Nov 12, 20251028:1015
  • Oct 1, 20181174:1053